library.onepin.app/pterostilbene Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider

OnePin Peptide Library · Longevity

Longevity Peptide

Pterostilbene

Pteroresveratrol

Pterostilbene (trans-3,5-dimethoxy-4'-hydroxystilbene) is a methylated analog of resveratrol found primarily in blueberries, grapes, and the Indian Kino tree (Pterocarpus marsupium - hence the name 'pterostilbene'). The two methoxy groups (-OCH3) replacing two of resveratrol's hydroxyl groups give pterostilbene dramatically improved oral bioavailability (~80% vs resveratrol's ~1%) and a much longer plasma half-life (~105 minutes vs resveratrol's ~14 minutes free form). Both compounds activate similar pathways (SIRT1, AMPK, autophagy) but pterostilbene's superior pharmacokinetics make it the more pharmacologically active stilbene at typical supplement doses.,Pterostilbene gained mainstream attention as the resveratrol analog used in Elysium Health's 'Basis' product (alongside nicotinamide riboside) and in numerous longevity-focused formulations. Clinical trials have demonstrated benefits on lipid markers, blood pressure, oxidative stress, and cognitive function. The University of Mississippi Pharmacology department has published extensively on pterostilbene's enhanced potency and bioavailability compared to resveratrol, showing that on a milligram-for-milligram basis, pterostilbene typically produces equivalent or stronger biological effects.,Beyond longevity research, pterostilbene has been studied for cardiovascular protection (cholesterol lowering at 125mg/day in human RCTs), cognitive enhancement (memory and processing speed in older adults), anti-cancer chemoprevention (preclinical), insulin sensitivity, and antioxidant effects. The methylation pattern that gives it bioavailability advantages also reduces phytoestrogen activity compared to resveratrol, making it potentially more suitable for hormone-sensitive populations. Standard supplement doses range from 50-250mg/day, often paired with NAD+ precursors for synergistic longevity protocols.

Quick Start
Route
Oral
Start low
100mg
Frequency
Daily
Timing
Anytime

Take with food (preferably containing some fat). Pairs naturally with NR/NMN as the substrate-activator combination. 50-250mg range covers most clinical use cases. Higher pharmacokinetic stability than resveratrol means once-daily dosing is sufficient for most purposes.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Quick Start
Conservative start
100mg · Oral · Daily
Lowest starting point. Hold about a week to assess tolerance before stepping up.
100mg
Daily
Standard
Sirtuin Activation
50-100 mg · Oral · Daily
human clinical trial · Riche et al. 2014 (Evid Based Complement Alternat Med)
50-100 mg
Daily
01

How it works

Pterostilbene shares resveratrol's primary mechanisms - SIRT1 activation (debated), AMPK activation (robust), and autophagy induction - but with substantially better in vivo activity due to superior pharmacokinetics. The two methoxy groups protect pterostilbene from the rapid sulfation/glucuronidation that limits resveratrol, resulting in 80% oral bioavailability vs 1% for resveratrol and tissue concentrations 100-300x higher per equivalent dose.,AMPK activation is dose-dependent and reproducible at physiologically achievable concentrations (low micromolar). Downstream effects include PGC-1alpha activation (mitochondrial biogenesis), mTOR inhibition (autophagy induction), reduced lipogenesis (lower hepatic triglyceride and LDL synthesis), and improved fatty acid oxidation. The metabolic shift mimics caloric restriction and exercise adaptations - similar to other AMPK activators (metformin, berberine, exercise itself).,Pterostilbene also has direct antioxidant activity (free radical scavenging via the polyphenol structure - more potent than resveratrol per mole), modulates Nrf2 pathway (cellular antioxidant defenses), inhibits NF-kB (anti-inflammatory), and has neuroprotective effects via reduced neuroinflammation and improved blood-brain barrier integrity. The methylation pattern reduces estrogen receptor binding compared to resveratrol, decreasing phytoestrogen activity - relevant for hormone-sensitive populations who may want pterostilbene's pathway benefits without the estrogenic profile.

Pterostilbene shares resveratrol's primary mechanisms - SIRT1 activation (debated), AMPK activation (robust), and autophagy induction - but with substantially better in vivo activity due to superior pharmacokinetics. The two methoxy groups protect pterostilbene from the rapid sulfation/glucuronidation that limits resveratrol, resulting in 80% oral bioavailability vs 1% for resveratrol and tissue concentrations 100-300x higher per equivalent dose.,AMPK activation is dose-dependent and reproducible at physiologically achievable concentrations (low micromolar). Downstream effects include PGC-1alpha activation (mitochondrial biogenesis), mTOR inhibition (autophagy induction), reduced lipogenesis (lower hepatic triglyceride and LDL synthesis), and improved fatty acid oxidation. The metabolic shift mimics caloric restriction and exercise adaptations - similar to other AMPK activators (metformin, berberine, exercise itself).,Pterostilbene also has direct antioxidant activity (free radical scavenging via the polyphenol structure - more potent than resveratrol per mole), modulates Nrf2 pathway (cellular antioxidant defenses), inhibits NF-kB (anti-inflammatory), and has neuroprotective effects via reduced neuroinflammation and improved blood-brain barrier integrity. The methylation pattern reduces estrogen receptor binding compared to resveratrol, decreasing phytoestrogen activity - relevant for hormone-sensitive populations who may want pterostilbene's pathway benefits without the estrogenic profile.

02

What to expect

Early
Days 1–7

Days 1-14: Subclinical AMPK activation. Some report subtle clarity.

03

Evidence

HumanPresent
AnimalPresent
In-vitroStrong
2013Analysis of safety from a human clinical trial with pterostilbene · Riche DM, McEwen CL, Riche KD, Sherman JJ, Wofford MR, Deschamp D, Griswold M, Journal of Toxicology ↗peer reviewed
2013Pterostilbene attenuates atherosclerosis through SIRT1 activation · Zhang L, Cui L, Zhou G, Jing H, Guo Y, Sun W, European Journal of Pharmacology ↗peer reviewed
2017Pterostilbene inhibits lipopolysaccharide-induced microglia activation and inflammation · Hou Y, Li N, Xie G, Wang J, Yuan Q, Jia C, Liu X, Li G, Tang Y, Wang B, Frontiers in Pharmacology ↗peer reviewed
2018Resveratrol and pterostilbene: a comparative overview of their chemistry, biosynthesis, plant sources and pharmacological properties · Lange KW, Li S, Plant Foods for Human Nutrition ↗review
04

Interactions & stacking

What's safe to combine, and what belongs in a separate pin.

Safe & synergistic

CurcuminBoth polyphenol anti-inflammatories with different molecular targets. Compatible no expected conflicts.
Omega-3 Fatty AcidsPterostilbene is fat-soluble; co-administration with omega-3 improves absorption. Anti-inflammatory complement.
BerberineBoth AMPK activators. Compatible but somewhat redundant - berberine is more potent for glucose control specifically.
Nicotinamide Riboside (NR)Pterostilbene activates SIRT1; SIRT1 requires NAD+. NR provides substrate, pterostilbene activates enzyme. The Basis (Elysium) formulation pairs them for this reason.

Keep separate

Anticoagulants (warfarin, apixaban, rivaroxaban)Like resveratrol, pterostilbene has antiplatelet activity. Bleeding risk increase when combined with anticoagulants. Discuss with prescribing physician.
CYP1A2 / CYP3A4 substrates (some medications)Pterostilbene may modestly inhibit certain CYP enzymes. Less clinically significant than resveratrol but worth pharmacist review for patients on multiple medications.
Surgery (within 2 weeks)Antiplatelet activity can increase intraoperative bleeding risk. Discontinue 2 weeks before scheduled surgery.
05

Pharmacokinetics

Illustrative plasma concentration · 24 h
Half-life
~105 minutes (parent compound) - ~7x longer than resveratrol
Peak · Tmax
~1-2 hours oral
Elimination
~12-24 hours
Activity
Effects sustained with daily dosing. Long half-life means once-daily dosing maintains effective tissue concentrations.

Storage. Store at room temperature (20-25C) in a cool, dry, dark place. Pterostilbene is more stable than resveratrol due to the methoxy groups but still light-sensitive. Capsules shelf-stable for 24+ months. Keep in opaque containers.

06

Regulatory status

Classified as a dietary supplement in the US (no FDA pre-approval required). Available widely over the counter. EU permits pterostilbene as a food supplement. ChromaDex's pTeroPure (the most-studied commercial form) has GRAS self-affirmation. Major branded products include Basis (Elysium) which combines pterostilbene with NR.

Put it to work

Calculate, log & track

Open Pterostilbene straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Pterostilbene in the app →

Go deeper

The guide & community

The complete Pterostilbene walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community